Official UK procurement notice
Abionics SA AbioSCOPE sensitivity enhancement project
Authority: Ministry of Defence (Central government)
What is being bought
Published requirement descriptionThis project will assess five different technical options to enhance the sensitivity of the Abionic MOTS ovalbumin IVD assay. The most favourable, or a combination of favourable options, will be optimised, evaluated and manufactured prior to assessment by Dstl.
CPV: Manual swab test kits
The lotProcurement structure
single lot · no lot value publishedLot #1
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32009L0081 Defence and Security Public Contracts Regulations 2011 (Directive 2009/81/EC)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 20 Oct 2023, 12:13 BST
- Last source update
- 20 Oct 2023, 12:13 BST
- FTS notice number
2023/S 000-031027- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-040db6Find a Tender
- Why no open competition
- The contract has as its object services listed in Annex II B to the directive
- Published justification
The UK Ministry of Defence has the requirement for a high technology readiness level solution that can detect threat materials in environmental samples with high specificity and sensitivity.
Dstl now intends to procure the services of Abionic SA (Switzerland) to enhance the sensitivity of the Abionic MOTS ovalbumin IVD assay.
This particular assay is a laboratory test consumable, which is an equipment-specific plastic disposable device that allows the sample to be manipulated and presented to a proprietary instrument: the AbioSCOPE.. It has been designed and developed incorporating task-specific component parts (in this case MoD GFE antibodies in combination with Abionic's proprietary formulation of chemicals) that can be applied to specifically determine the presence of a substance (in this case the model protein, ovalbumin).
The procurement of these assays are required to meet specific customer specifications for analysis. A single source justification is deemed necessary in this instance, under Section 34 Regulation 32(5)(b); where the assays are intended to serve as a “(b) addition to an existing installation” (in this instance, the existing AbioSCOPE). A change in supplier would oblige Dstl to acquire supplies of different technical characteristics, resulting in the sourcing of a new instrument and a separate supply of consumables, changes to service support maintenance, as well as disproportionate technical difficulties in its operability (in this instance, changes to current uncertainties reported to our customer). Most significantly, there will be the necessity to fully revalidate methods on to the new instrument, causing an unacceptable burden on resources and a delay in the delivery of high priority work for the CBR S&T programme.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Abionic SASMEAbionicsSubcontracting: declared | CHF 153,000 † | — | Awarded |
Contracts
Abionics · Abionic SASME
- Signed
- 17 Oct 2023
- Value
- CHF 153,000
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- DSTLReview body
Bidders & participating suppliers
1 commercial party on the notice- Abionic SAAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.